Protara Therapeutics (TARA) Return on Capital Employed Growth (5y) (2019 - 2026)
Protara Therapeutics (TARA) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Protara Therapeutics |
216.35 Mn |
216.35 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,706.00 |
| Dec 31, 2025 |
-2,147.00 |
| Sep 30, 2025 |
-2,042.00 |
| Jun 30, 2025 |
-222.00 |
| Mar 31, 2025 |
2,302.00 |
| Dec 31, 2024 |
33,687.00 |
| Sep 30, 2024 |
5,881.00 |
| Jun 30, 2024 |
4,315.00 |
| Mar 31, 2024 |
3,333.00 |
| Sep 30, 2023 |
2,797.00 |
| Jun 30, 2023 |
2,346.00 |
| Mar 31, 2023 |
3,290.00 |
| Sep 30, 2022 |
7,423.00 |
| Jun 30, 2022 |
6,323.00 |
| Mar 31, 2022 |
4,976.00 |
| Sep 30, 2021 |
3,341.00 |
| Jun 30, 2021 |
2,505.00 |
| Mar 31, 2021 |
1,844.00 |
| Dec 31, 2020 |
1,434.00 |
| Sep 30, 2020 |
318.00 |
